HIGHLIGHTS
- What: Four patients with NS-MPD were included in the study ; their baseline characteristics are presented in Table 2. The work provides additional insight into the expected time to spontaneous resolution of NS-MPD in those with germline PTPN11 mutations and treatment approaches for patients with germline CBL mutations where no standard exists.
- Who: Bryony J. Lucas et al. from the Department of Pediatrics, Baylor College of Medicine, Texas Children`s Cancer and Hematology Center, Houston, TX, USA Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA have published the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.